Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Data: Axios/Ipsos Poll; Note: 3.3% margin of error; Chart: Andrew Witherspoon/Axios

Most Americans support the pause in distribution of the Johnson & Johnson COVID-19 vaccine, and so far there's no evidence that it's leading to broader vaccine hesitancy, according to the latest installment of the Axios/Ipsos Coronavirus Index.

Driving the news: In our weekly national survey, 91% of respondents were aware of the temporary pause recommended by the Food and Drug Administration and the Centers for Disease for Control and Prevention. Of those, 88% said the pause was a responsible decision.

  • Republicans were almost as likely to support the pause as Democrats, an indication this issue hasn't been politicized.
  • The fact that 91% knew about it within the first few days is an extremely high level of awareness for a news event, and indicates how closely Americans are following vaccine news.
  • 98% of Americans 65 and older said they were aware of the pause.

Why it matters: Some officials have expressed concern that the handling of the pause could needlessly scare some Americans from getting vaccinated and make it harder to reach the vaccination levels needed to get the virus under control.

  • But the survey finds no indication of this yet. Asked how likely they are to get the first generation vaccine as soon as it's available, 30 percent said they're not likely to — the same share that has said so for the last month, and far lower than the peak of 63% last September.

What they're saying: "People are unfazed," said Cliff Young, president of Ipsos U.S. Public Affairs. "The way forward is about the vaccine, so if there’s any stumble people are going to pay attention to it — but it hasn’t had an impact thus far" on willingness to get the vaccine.

  • He said 91% societal awareness over last week's pause is "super impressive" — greater than one would likely see with a question like who won the Super Bowl, and more akin to results of a presidential election result or even 9/11 in terms of instant awareness.
  • That's driven by the public's intense desire to return to normalcy, he said, and "the perception is the vaccines are so essential for getting back to normal."

What we're watching: 7% said they knew someone who had traveled to another state to get the vaccine.

  • Three-fourths of those who have been vaccinated say they found shots within half an hour of their homes, with another 20% saying they had to travel between 30 minutes and an hour.
  • Only 3% overall traveled more than an hour for their shots— but that rose to 10% among 18-to-29 year olds and 7% among people who live in rural areas.

The big picture: The survey found Americans are increasingly leaving their homes, with historically low numbers since the start of the pandemic on those who are self-quarantining (11%) and social distancing (61%) and high numbers for those going out to eat (48%).

  • Only 63% are saying they are wearing a mask at all times when they leave home, the lowest since we began asking the question last July — and 13% say they never or only occasionally wear masks, a survey high.

Methodology: This Axios/Ipsos Poll was conducted April 16-19 by Ipsos' KnowledgePanel®. This poll is based on a nationally representative probability sample of 1,033 general population adults age 18 or older.

  • The margin of sampling error is ±3.3 percentage points at the 95% confidence level, for results based on the entire sample of adults.

Go deeper

Bryan Walsh, author of Future
Jul 29, 2021 - Health

Testing our way around the Delta surge

Illustration: Aïda Amer/Axios

The recent surge of COVID-19 cases is strengthening the case for more frequent testing.

Why it matters: The more contagious Delta variant threatens the fuller reopening of offices and schools in the fall. But regular testing — especially with cheap and almost instantaneous tests — could help catch cases before they have a chance to spread.

Jul 29, 2021 - Health

Israel to offer third COVID vaccine dose to people over 60

A woman receives her third dose of COVID19 vaccine at Sheba Medical Center on July 14, 2021 in Israel. Photo: Amir Levy/Getty Images

Israel will begin offering a third shot of the coronavirus vaccine to people over the age of 60 starting Sunday, Haaretz reports.

Why it matters: Israel will become the first country to begin giving booster shots, per Haaretz. The country will offer doses to those over 60 who received their second dose at least five months ago.

Jul 29, 2021 - Health

The billion-dollar COVID booster discussion

A third dose of the COVID-19 vaccine could add billions of dollars in extra revenue for Pfizer. Photo: Michael Nagle/Bloomberg via Getty Images

Pfizer said yesterday that it expects to sell nearly $34 billion worth of coronavirus vaccines this year — and there could be billions more behind that, if people who have gotten the shot ultimately need boosters.

Why it matters: It's unclear whether, when and for whom a coronavirus vaccine booster will be necessary. Pfizer has a lot of money riding on those answers, and executives are already making the case that many Americans will need a third dose.